Focuses on the advancements of gene transfer-based strategies for Duchenne and limb-girdle muscular dystrophies. Identification of dystrophin as the causative factor in the diseases; Generation of a number of genetically engineered murine models for muscular dystrophy; Pathogenesis of the disorders.